Search
for
Sort by
Research 781–810 of 1000+
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Current evaluation of amenorrhea
- Progesterone, neurosteroids, and the hormonal basis of catamenial epilepsy
- Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity
- Clinical Profiles, Occurrence, and Management of Adolescent Patients with HAIR-AN Syndrome
- Women’s Health Care During the Perimenopause
- Spironolactone in the Treatment of Hirsutism
- Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
- Therapeutic options in the polycystic ovary syndrome
- A Facile Synthesis of Mollugin
- Hirsutism and virilization
- [Assessment of efficacy of Diane-35 in androgenetic feminine alopecia].
- Idiopathic hirsutism: excessive bodily and facial hair in women
- Polycystic Ovary Syndrome
- Choice of treatment for women with polycystic ovary syndrome
- Polycystic Ovary Syndrome
- Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol
- Efficacy of two traditionally used potentized homeopathic medicines, Calcarea carbonica and Lycopodium clavatum, used for treating PCOS patients: I. Effects on certain important external guiding symptoms
- Management of Clinical Side Effects of DMPA
- Polycystic ovarian syndrome and associated hirsutism in the adolescent
- Hot Flashes in a Young Girl: A Wake-up Call Concerning Serenoa repens Use in Children
- Parenteral and Oral Cyproterone Acetate Treatment in Severe Hirsutism
- Nuclear and cytosol Androgen Receptor in Androgen Dependent Dermatoses in Female Patients
- Role of Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate for the Maintenance of Axillary Hair in Women
- Long-Term Morbidity of PCOS
- Menopause
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome
- A STUDY OF CLINICAL PARAMETERS IN THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME
- The metabolic effects of drugs used for the treatment of polycystic ovary syndrome